Initial public offerings by biopharmaceutical companies continue at a rapid pace in the US and August could see one of 2020’s biggest IPOs if the German messenger RNA (mRNA)-based vaccine developer CureVac BV goes public as planned this month.
Twelve drug developers went public in the US during July, including Allovir, Inc. on 30 July, after 14 biopharma...






